Posted on Leave a comment

Nebulizers Market to Witness a Sudden Rise in Growth During the Forecast Period | Companies- Koninklijke Philips N.V., Omron Healthcare, Inc., Aerogen, PARI GmbH, GF Health Products

Nebulizers Market Nebulizers Market By Type (Pneumatic Nebulizer, Ultrasonic Nebulizer, Mesh Nebulizer), By Portability (Tabletop Nebulizer, Portable Nebulizer), By End-User (Hospitals and Clinics, Ambulatory Surgical Centers (ASC), Emergency Centers, Others), By Geography is expected to grow at a steady CAGR forecast till 2028 owing to outbreak of the covid-19 pandemic and surge in cigarette smoking. […]

Posted on Leave a comment

Capitol Ketamine & Wellness Provides Medically Supervised Ketamine Infusion Therapy in Washington, DC

“At Capitol Ketamine & Wellness, we are dedicated to bringing the most innovative, research-backed solutions to managing mental and physical health,” says Dr. Allyson Bloom, Capitol Ketamine & Wellness Co-Founder. “We use the most advanced therapies, such as Ketamine Infusion Therapy, and are well versed in the safety profile, side effects, and protocols to deliver […]

Posted on Leave a comment

Metastatic Prostate Cancer Pipeline Analysis, 2023 Updates | Latest FDA, EMA, and PMDA Approvals | Merck & Co, Pfizer, Orion, Zenith Epigenetics, ESSA Pharma, RhoVac, AstraZeneca, Advaxis, Inc.

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Metastatic Prostate Cancer pipeline constitutes 90+ key companies continuously working towards developing 110+ Metastatic Prostate Cancer treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Metastatic Prostate Cancer Pipeline report embraces in-depth commercial and clinical assessment […]

Posted on Leave a comment

Generative AI in Healthcare Market Size to Hit USD 24,218 Mn by 2033

Generative AI in Healthcare Market – Upcoming Trends Analysis By 2033 Generative AI in Healthcare Market is forecasted to grow by USD 24,218 Mn during 2023-2033, accelerating at a CAGR of 37.2% during the forecast period. Generative AI in Healthcare Market is projected to achieve a value of USD 3,753 Million in 2023, with a […]

Posted on Leave a comment

Homozygous Familial Hypercholesterolemia Market to Exhibit Rapid Growth Rate During the Forecast Period (2023-2032), Investigates DelveInsight | Amryt Pharma, Novartis, Ultragenyx Pharma, Arrowhead

DelveInsight’s “Homozygous Familial Hypercholesterolemia Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Homozygous Familial Hypercholesterolemia, historical and forecasted epidemiology as well as the Homozygous Familial Hypercholesterolemia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. DelveInsight’s “Homozygous Familial Hypercholesterolemia Market Insights, Epidemiology, and […]

Posted on Leave a comment

Dysmenorrhea Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | ObsEva SA, Fuji Pharma’s, Bayer, Juniper Pharmaceuticals, Inc., Nobelpharma

DelveInsight’s “Dysmenorrhea Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Dysmenorrhea, historical and forecasted epidemiology as well as the Dysmenorrhea market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. DelveInsight’s “Dysmenorrhea Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of […]

Posted on Leave a comment

EGFR Non Small Cell Lung Cancer Pipeline Drugs Analysis Report, 2023: FDA Approvals, Clinical Trials, Therapies, Mechanism of Action, Route of Administration by DelveInsight | Avistone Pharma

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, EGFR Non Small Cell Lung Cancer pipeline constitutes 40+ key companies continuously working towards developing 42+ EGFR Non Small Cell Lung Cancer treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The EGFR Non Small Cell Lung […]

Posted on Leave a comment

Respiratory Syncytial Virus (RSV) Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Enanta, ReViral, Pfizer, Sanofi, BioComo

Delveinsight Business Research LLP As per DelveInsight’s assessment, globally, about 50+ key pharma and biotech companies are working on 50+ pipeline drugs in the Respiratory Syncytial Virus therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development […]

Posted on Leave a comment

Geographic Atrophy Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Ionis, IVERIC bio, Apellis, Annexon, Novartis, Astellas

Delveinsight Business Research LLP As per DelveInsight’s assessment, globally, about 23+ key pharma and biotech companies are working on 25+ pipeline drugs in the Geographic Atrophy therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and […]

Posted on Leave a comment

Acute Lymphocytic Leukemia Pipeline Analysis, 2023 Updates | Latest FDA, EMA, and PMDA Approvals | Pfizer, Genentech, Inc., Jazz Pharma, Sanofi, PeproMene Bio, Inc., Kymera Therapeutics, Inc., Amgen

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Acute Lymphocytic Leukemia pipeline constitutes 150+ key companies continuously working towards developing 160+ Acute Lymphocytic Leukemia treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Acute Lymphocytic Leukemia Pipeline report embraces in-depth commercial and clinical assessment […]